Inventia Life Science has announced the release of RASTRUM™ Allegro, a new development in 3D cell culture technology aimed at addressing challenges in drug discovery and disease research.

RASTRUM Allegro is designed to offer researchers a platform that supports the creation of scalable, reproducible 3D cell models. This advancement is expected to facilitate more consistent and biologically relevant research outcomes, addressing issues related to the limited availability of patient-derived cells and the need for reliable models in laboratory settings.

Julio Ribeiro, Founder and CEO of Inventia Life Science, commented, “We developed RASTRUM Allegro to give researchers the ability to generate complex 3D cell models that better represent human biology. Our goal is to provide the precision and scalability needed to support scientific discovery and deepen biological understanding.”

RASTRUM Allegro simplifies the 3D cell culture workflow by allowing direct sample handling from primary tubes and automating several steps that typically require manual intervention. This approach not only reduces the potential for error but also streamlines the overall process, making high-throughput applications more feasible.

Cameron Ferris, PhD, COO at Inventia Life Science, highlighted the practical applications of RASTRUM Allegro in research settings:
"RASTRUM Allegro addresses a longstanding issue in the field—balancing biological complexity with scalability. It enables researchers to conduct high-throughput 3D cell culture without sacrificing reproducibility, offering a new way to explore disease phenotypes and drug responses."